HSPA5 and cancer: Beyond viral infection, BiP is elevated in numerous cancers, including leukemia, melanoma, multiple myeloma, brain, pancreatic, liver, and breast cancer, and is regarded as a promising biomarker and therapeutic target in several diseases [22].